ArticleFrontiers in oncology2025

An MRI radiomics model for predicting a prostate-specific antigen response following abiraterone treatment in patients with metastatic castration-resistant prostate cancer.

Yi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.